Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christopher N. Treinen"'
Autor:
Shireen Vali, Georgia K. Johnson, Janet M. Guthmiller, Kim A. Brogden, Christopher N. Treinen, Emily E. Starman, Carol L. Fischer, Emily A. Lanzel, Deepak Parashar, Taher Abbasi, M. Paula Gomez Hernandez, Amber M. Bates
Publikováno v:
Cancer immunology, immunotherapy : CII. 65(12)
Interaction of the programmed death-1 (PD-1) co-receptor on T cells with the programmed death-ligand 1 (PD-L1) on tumor cells can lead to immunosuppression, a key event in the pathogenesis of many tumors. Thus, determining the amount of PD-L1 in tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71470e9f429bb874ace71cf5fd7ef3a8
https://pubmed.ncbi.nlm.nih.gov/27688163
https://pubmed.ncbi.nlm.nih.gov/27688163
Autor:
Shireen Vali, Carol L. Fischer, Amber M. Bates, Emily A. Lanzel, Christopher N. Treinen, Prashant Ramachandran Nair, Taher Abbasi, Maria Paula Gomez Hernandez, Kim A. Brogden, Erica N. Recker, Karthik Sundara, Vishwas Joseph
Publikováno v:
Blood. 126:1803-1803
Introduction: Immunotherapy is an exciting new option to stimulate a "host-vs.-cancer" effect. Such treatment regimens are dominated by Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) immune checkpoint inhibitors. However, not all pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7de8aa55b85d75d446532658afc25da2
https://doi.org/10.1182/blood.v126.23.1803.1803
https://doi.org/10.1182/blood.v126.23.1803.1803